Long-term effects of aromatase inhibitors on body mass index among postmenopausal breast cancer survivors in Africa: observational cohort study
Purpose this study was conducted to assess the impact of AIs on body mass index and high sensitivity as prognostic predictors to be incorporated into point of care technology (POCT) testing in postmenopausal breast cancer women after a 24 month follow up in Africa. An observational cohort study was...
Gespeichert in:
| Veröffentlicht in: | BMC research notes Jg. 16; H. 1; S. 37 - 5 |
|---|---|
| Hauptverfasser: | , , , |
| Format: | Journal Article |
| Sprache: | Englisch |
| Veröffentlicht: |
London
BioMed Central
13.03.2023
BioMed Central Ltd Springer Nature B.V BMC |
| Schlagworte: | |
| ISSN: | 1756-0500, 1756-0500 |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| Abstract | Purpose
this study was conducted to assess the impact of AIs on body mass index and high sensitivity as prognostic predictors to be incorporated into point of care technology (POCT) testing in postmenopausal breast cancer women after a 24 month follow up in Africa. An observational cohort study was conducted; including 126 female BC patients with stages ranging from 0-III initially subjected to AIs and subsequently followed up for 24 months. Multiple imputation model was conducted to predict missing data.
Results
Random effects model was used to monitor the changes over the time. The study revealed stronger statistically association between BMI and homocysteine (p = 0.021, 95%CI: 0.0083 to 0.1029). Weight and total body fat were strongly associated after 24 months follow up. Hs-CRP was associated with BMI (p = 0.0001), and hs-CRP was associated with other biomedical markers such as calcium (p = 0.021, 95% CI: 0.01 to 0.10), phosphate (p = 0.039, 95%CI: 0.01 to 0.10), and ferritin (p = 0.002, 95%CI: 0.02 to 0.08) and calcium. The patients subjected to AIs are likely to develop cardiovascular adverse events. POCT of care strategy which include clinical, biomedical and genetic predictor’s measurement is required to improve BC survivorship. |
|---|---|
| AbstractList | Purpose this study was conducted to assess the impact of AIs on body mass index and high sensitivity as prognostic predictors to be incorporated into point of care technology (POCT) testing in postmenopausal breast cancer women after a 24 month follow up in Africa. An observational cohort study was conducted; including 126 female BC patients with stages ranging from 0-III initially subjected to AIs and subsequently followed up for 24 months. Multiple imputation model was conducted to predict missing data. Results Random effects model was used to monitor the changes over the time. The study revealed stronger statistically association between BMI and homocysteine (p = 0.021, 95%CI: 0.0083 to 0.1029). Weight and total body fat were strongly associated after 24 months follow up. Hs-CRP was associated with BMI (p = 0.0001), and hs-CRP was associated with other biomedical markers such as calcium (p = 0.021, 95% CI: 0.01 to 0.10), phosphate (p = 0.039, 95%CI: 0.01 to 0.10), and ferritin (p = 0.002, 95%CI: 0.02 to 0.08) and calcium. The patients subjected to AIs are likely to develop cardiovascular adverse events. POCT of care strategy which include clinical, biomedical and genetic predictor's measurement is required to improve BC survivorship. Keywords: Aromatase inhibitors, High sensitivity C-reactive protein, Body mass index, Postmenopausal breast cancer, And multiple imputations this study was conducted to assess the impact of AIs on body mass index and high sensitivity as prognostic predictors to be incorporated into point of care technology (POCT) testing in postmenopausal breast cancer women after a 24 month follow up in Africa. An observational cohort study was conducted; including 126 female BC patients with stages ranging from 0-III initially subjected to AIs and subsequently followed up for 24 months. Multiple imputation model was conducted to predict missing data. Random effects model was used to monitor the changes over the time. The study revealed stronger statistically association between BMI and homocysteine (p = 0.021, 95%CI: 0.0083 to 0.1029). Weight and total body fat were strongly associated after 24 months follow up. Hs-CRP was associated with BMI (p = 0.0001), and hs-CRP was associated with other biomedical markers such as calcium (p = 0.021, 95% CI: 0.01 to 0.10), phosphate (p = 0.039, 95%CI: 0.01 to 0.10), and ferritin (p = 0.002, 95%CI: 0.02 to 0.08) and calcium. The patients subjected to AIs are likely to develop cardiovascular adverse events. POCT of care strategy which include clinical, biomedical and genetic predictor's measurement is required to improve BC survivorship. Purpose this study was conducted to assess the impact of AIs on body mass index and high sensitivity as prognostic predictors to be incorporated into point of care technology (POCT) testing in postmenopausal breast cancer women after a 24 month follow up in Africa. An observational cohort study was conducted; including 126 female BC patients with stages ranging from 0-III initially subjected to AIs and subsequently followed up for 24 months. Multiple imputation model was conducted to predict missing data. Results Random effects model was used to monitor the changes over the time. The study revealed stronger statistically association between BMI and homocysteine (p = 0.021, 95%CI: 0.0083 to 0.1029). Weight and total body fat were strongly associated after 24 months follow up. Hs-CRP was associated with BMI (p = 0.0001), and hs-CRP was associated with other biomedical markers such as calcium (p = 0.021, 95% CI: 0.01 to 0.10), phosphate (p = 0.039, 95%CI: 0.01 to 0.10), and ferritin (p = 0.002, 95%CI: 0.02 to 0.08) and calcium. The patients subjected to AIs are likely to develop cardiovascular adverse events. POCT of care strategy which include clinical, biomedical and genetic predictor’s measurement is required to improve BC survivorship. Abstract Purpose this study was conducted to assess the impact of AIs on body mass index and high sensitivity as prognostic predictors to be incorporated into point of care technology (POCT) testing in postmenopausal breast cancer women after a 24 month follow up in Africa. An observational cohort study was conducted; including 126 female BC patients with stages ranging from 0-III initially subjected to AIs and subsequently followed up for 24 months. Multiple imputation model was conducted to predict missing data. Results Random effects model was used to monitor the changes over the time. The study revealed stronger statistically association between BMI and homocysteine (p = 0.021, 95%CI: 0.0083 to 0.1029). Weight and total body fat were strongly associated after 24 months follow up. Hs-CRP was associated with BMI (p = 0.0001), and hs-CRP was associated with other biomedical markers such as calcium (p = 0.021, 95% CI: 0.01 to 0.10), phosphate (p = 0.039, 95%CI: 0.01 to 0.10), and ferritin (p = 0.002, 95%CI: 0.02 to 0.08) and calcium. The patients subjected to AIs are likely to develop cardiovascular adverse events. POCT of care strategy which include clinical, biomedical and genetic predictor’s measurement is required to improve BC survivorship. this study was conducted to assess the impact of AIs on body mass index and high sensitivity as prognostic predictors to be incorporated into point of care technology (POCT) testing in postmenopausal breast cancer women after a 24 month follow up in Africa. An observational cohort study was conducted; including 126 female BC patients with stages ranging from 0-III initially subjected to AIs and subsequently followed up for 24 months. Multiple imputation model was conducted to predict missing data.PURPOSEthis study was conducted to assess the impact of AIs on body mass index and high sensitivity as prognostic predictors to be incorporated into point of care technology (POCT) testing in postmenopausal breast cancer women after a 24 month follow up in Africa. An observational cohort study was conducted; including 126 female BC patients with stages ranging from 0-III initially subjected to AIs and subsequently followed up for 24 months. Multiple imputation model was conducted to predict missing data.Random effects model was used to monitor the changes over the time. The study revealed stronger statistically association between BMI and homocysteine (p = 0.021, 95%CI: 0.0083 to 0.1029). Weight and total body fat were strongly associated after 24 months follow up. Hs-CRP was associated with BMI (p = 0.0001), and hs-CRP was associated with other biomedical markers such as calcium (p = 0.021, 95% CI: 0.01 to 0.10), phosphate (p = 0.039, 95%CI: 0.01 to 0.10), and ferritin (p = 0.002, 95%CI: 0.02 to 0.08) and calcium. The patients subjected to AIs are likely to develop cardiovascular adverse events. POCT of care strategy which include clinical, biomedical and genetic predictor's measurement is required to improve BC survivorship.RESULTSRandom effects model was used to monitor the changes over the time. The study revealed stronger statistically association between BMI and homocysteine (p = 0.021, 95%CI: 0.0083 to 0.1029). Weight and total body fat were strongly associated after 24 months follow up. Hs-CRP was associated with BMI (p = 0.0001), and hs-CRP was associated with other biomedical markers such as calcium (p = 0.021, 95% CI: 0.01 to 0.10), phosphate (p = 0.039, 95%CI: 0.01 to 0.10), and ferritin (p = 0.002, 95%CI: 0.02 to 0.08) and calcium. The patients subjected to AIs are likely to develop cardiovascular adverse events. POCT of care strategy which include clinical, biomedical and genetic predictor's measurement is required to improve BC survivorship. this study was conducted to assess the impact of AIs on body mass index and high sensitivity as prognostic predictors to be incorporated into point of care technology (POCT) testing in postmenopausal breast cancer women after a 24 month follow up in Africa. An observational cohort study was conducted; including 126 female BC patients with stages ranging from 0-III initially subjected to AIs and subsequently followed up for 24 months. Multiple imputation model was conducted to predict missing data. Random effects model was used to monitor the changes over the time. The study revealed stronger statistically association between BMI and homocysteine (p = 0.021, 95%CI: 0.0083 to 0.1029). Weight and total body fat were strongly associated after 24 months follow up. Hs-CRP was associated with BMI (p = 0.0001), and hs-CRP was associated with other biomedical markers such as calcium (p = 0.021, 95% CI: 0.01 to 0.10), phosphate (p = 0.039, 95%CI: 0.01 to 0.10), and ferritin (p = 0.002, 95%CI: 0.02 to 0.08) and calcium. The patients subjected to AIs are likely to develop cardiovascular adverse events. POCT of care strategy which include clinical, biomedical and genetic predictor's measurement is required to improve BC survivorship. Purposethis study was conducted to assess the impact of AIs on body mass index and high sensitivity as prognostic predictors to be incorporated into point of care technology (POCT) testing in postmenopausal breast cancer women after a 24 month follow up in Africa. An observational cohort study was conducted; including 126 female BC patients with stages ranging from 0-III initially subjected to AIs and subsequently followed up for 24 months. Multiple imputation model was conducted to predict missing data.ResultsRandom effects model was used to monitor the changes over the time. The study revealed stronger statistically association between BMI and homocysteine (p = 0.021, 95%CI: 0.0083 to 0.1029). Weight and total body fat were strongly associated after 24 months follow up. Hs-CRP was associated with BMI (p = 0.0001), and hs-CRP was associated with other biomedical markers such as calcium (p = 0.021, 95% CI: 0.01 to 0.10), phosphate (p = 0.039, 95%CI: 0.01 to 0.10), and ferritin (p = 0.002, 95%CI: 0.02 to 0.08) and calcium. The patients subjected to AIs are likely to develop cardiovascular adverse events. POCT of care strategy which include clinical, biomedical and genetic predictor’s measurement is required to improve BC survivorship. |
| ArticleNumber | 37 |
| Audience | Academic |
| Author | Akudugu, John M Milambo, Jean Paul Muambangu Ndirangu, James Nyasulu, Peter S |
| Author_xml | – sequence: 1 givenname: Jean Paul Muambangu orcidid: 0000-0003-0552-5378 surname: Milambo fullname: Milambo, Jean Paul Muambangu email: jeanpaulmilambo2@gmail.com organization: Department of Health Sciences, Division of Public Health, University of Free state – sequence: 2 givenname: Peter S surname: Nyasulu fullname: Nyasulu, Peter S organization: Department of Global Health, Division of Epidemiology and Biostatistics, Faculty of Medicine and Health Sciences, Stellenbosch University – sequence: 3 givenname: John M surname: Akudugu fullname: Akudugu, John M organization: Division of Radiobiology, Department of Medical Imaging and Clinical Oncology, Faculty of Medicine and Health Sciences, Stellenbosch University – sequence: 4 givenname: James surname: Ndirangu fullname: Ndirangu, James organization: Department of Health Sciences, Division of Public Health, University of Free State |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/36915158$$D View this record in MEDLINE/PubMed |
| BookMark | eNp9kstqGzEUhoeS0lzaF-iiCLppF5PqMhdNN8GEXgyBbNpuhUY6Gst4JFfSmPgp-sqV7TSJSykCaTj6_n84R_95ceK8g6J4TfAlIbz5EAkjuCoxZSVuGCZl86w4I23dlLjG-OTJ92lxHuMS44ZwTl4Up6zpSE1qflb8uvFuKBOEEYExoFJE3iAZ_CiTjICsW9jeJh9y3aHe6y0aZYy5ruEOyTGr0drHNILzazlFuUJ9ABkTUtIpCChOYWM3O711aGaCVfIj8n2EsJHJepcFyi98SCimSW9fFs-NXEV4dX9eFN8_f_p2_bW8uf0yv57dlKruWCo71hPK8waGUKC5H46pabpOAyNti7Hpqa57QxUBXFWqJ3VTdUa3hqlKYs4uivnBV3u5FOtgRxm2wksr9gUfBiFDsmoFQmfXWgFVXFcVNVT21BCjecOIqQ2w7HV18FpP_QhagUtBro5Mj2-cXYjBbwTBmND8PNnh3b1D8D8niEmMNipYraQDP0VBW95wwnhdZ_TtX-jSTyGPcU_xqm05rh6pQeYOrDM-_1jtTMWsrQhpKaM0U5f_oPLSMFqVw2Zsrh8J3h8JMpPgLg354aOY3_44Zt88ncrDOP5kLwP0AKjgYwxgHhCCxS7g4hBwkQMu9gEXTRaxgyhm2A0QHtv_j-o38fn9sg |
| Cites_doi | 10.1100/2011/806787 10.1007/s11749-018-0612-4 10.1016/j.jnci.2015.09.001 10.2174/1381612826666200908141858 10.1200/JCO.2015.64.3809 10.1155/2013/291546 10.1177/1178223417743976 10.1093/jnci/djr242 10.5395/rde.2014.39.1.74 10.1007/s10549-010-0990-0 10.5306/wjco.v5.i3.283 10.1371/journal.pone.0146413 10.1093/ije/dyp309 10.2217/pgs-2016-0205 10.1007/s11864-019-0646-1 10.1089/jwh.2009.1365 10.1371/journal.pone.0184174 10.1007/s10549-011-1843-1 10.7717/peerj.4794 10.3102/1076998616687084 10.1016/j.clbc.2011.03.013 10.3109/07357907.2013.789898 10.1186/s12982-017-0062-6 10.1007/s11864-018-0541-1 10.1016/j.tem.2011.10.003 10.1016/j.clbc.2016.02.011 10.1073/pnas.1007983107 10.1155/2013/697521 10.1001/jamaoncol.2018.5327 10.2147/PGPM.S35063 10.2217/pme.13.43 10.1109/JTEHM.2017.2761764 10.1155/2015/145647 10.1186/1471-2288-11-129 10.1158/1055-9965.EPI-15-1061 10.1159/000345045 |
| ContentType | Journal Article |
| Copyright | The Author(s) 2023 2023. The Author(s). COPYRIGHT 2023 BioMed Central Ltd. 2023. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
| Copyright_xml | – notice: The Author(s) 2023 – notice: 2023. The Author(s). – notice: COPYRIGHT 2023 BioMed Central Ltd. – notice: 2023. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
| DBID | C6C AAYXX CITATION CGR CUY CVF ECM EIF NPM IOV 3V. 7X7 7XB 88E 8FE 8FH 8FI 8FJ 8FK ABUWG AFKRA AZQEC BBNVY BENPR BHPHI CCPQU DWQXO FYUFA GHDGH GNUQQ HCIFZ K9. LK8 M0S M1P M7P PHGZM PHGZT PIMPY PJZUB PKEHL PPXIY PQEST PQGLB PQQKQ PQUKI PRINS 7X8 5PM DOA |
| DOI | 10.1186/s13104-023-06301-6 |
| DatabaseName | Springer Nature Link CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Gale In Context: Opposing Viewpoints ProQuest Central (Corporate) Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) ProQuest SciTech Collection ProQuest Natural Science Collection Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central ProQuest Central UK/Ireland ProQuest Central Essentials Biological Science Collection ProQuest Central Natural Science Collection ProQuest One Community College ProQuest Central Korea Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student SciTech Premium Collection ProQuest Health & Medical Complete (Alumni) ProQuest Biological Science Collection Health & Medical Collection (Alumni Edition) Medical Database Biological Science Database ProQuest Central Premium ProQuest One Academic (New) ProQuest Publicly Available Content Database ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Applied & Life Sciences ProQuest One Academic (retired) ProQuest One Academic UKI Edition ProQuest Central China MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Publicly Available Content Database ProQuest Central Student ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) SciTech Premium Collection ProQuest One Community College ProQuest One Health & Nursing ProQuest Natural Science Collection ProQuest Central China ProQuest Central ProQuest One Applied & Life Sciences ProQuest Health & Medical Research Collection Health Research Premium Collection Health and Medicine Complete (Alumni Edition) Natural Science Collection ProQuest Central Korea Health & Medical Research Collection Biological Science Collection ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest Biological Science Collection ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) Biological Science Database ProQuest SciTech Collection ProQuest Hospital Collection (Alumni) ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE MEDLINE - Academic Publicly Available Content Database |
| Database_xml | – sequence: 1 dbid: DOA name: DOAJ (Directory of Open Access Journals) url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: PIMPY name: Publicly Available Content Database url: http://search.proquest.com/publiccontent sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Biology |
| EISSN | 1756-0500 |
| EndPage | 5 |
| ExternalDocumentID | oai_doaj_org_article_d99d5ce2c8d442f2ab2f1fd8631f5fe3 PMC10012500 A741172322 36915158 10_1186_s13104_023_06301_6 |
| Genre | Journal Article Observational Study |
| GeographicLocations | Africa |
| GeographicLocations_xml | – name: Africa |
| GrantInformation_xml | – fundername: Neurosurgical Research Foundation grantid: 18715567 funderid: http://dx.doi.org/10.13039/501100001039 – fundername: Neurosurgical Research Foundation grantid: 18715567 – fundername: ; grantid: 18715567 |
| GroupedDBID | --- 0R~ 23N 2WC 53G 5GY 5VS 6J9 7X7 88E 8FE 8FH 8FI 8FJ AAFWJ AAJSJ AASML ABDBF ABUWG ACGFO ACGFS ACIHN ACMJI ACPRK ACUHS ADBBV ADRAZ ADUKV AEAQA AFKRA AFPKN AHBYD AHMBA AHYZX ALMA_UNASSIGNED_HOLDINGS AMKLP AMTXH AOIJS BAPOH BAWUL BBNVY BCNDV BENPR BFQNJ BHPHI BMC BPHCQ BVXVI C6C CCPQU CS3 DIK E3Z EBD EBLON EBS EMOBN ESX F5P FYUFA GROUPED_DOAJ GX1 HCIFZ HMCUK HYE IAO IEA IHR INH INR IOV ITC KQ8 LK8 M1P M48 M7P MK0 M~E O5R O5S OK1 OVT P2P PGMZT PHGZM PHGZT PIMPY PJZUB PPXIY PQGLB PQQKQ PROAC PSQYO PUEGO RBZ RNS ROL RPM RSV SBL SOJ SV3 TR2 TUS UKHRP ~8M AAYXX AFFHD CITATION -A0 3V. ACRMQ ADINQ ALIPV C24 CGR CUY CVF ECM EIF NPM 7XB 8FK AZQEC DWQXO GNUQQ K9. PKEHL PQEST PQUKI PRINS 7X8 5PM |
| ID | FETCH-LOGICAL-c593t-93b1283b1ef12e2369802f699de317700fb2d5bf2c1e044cb15649fd7f3c4a083 |
| IEDL.DBID | RSV |
| ISICitedReferencesCount | 0 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000948971800002&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 1756-0500 |
| IngestDate | Fri Oct 03 12:36:53 EDT 2025 Tue Nov 04 02:07:12 EST 2025 Fri Sep 05 14:49:28 EDT 2025 Sat Oct 11 05:42:51 EDT 2025 Tue Nov 11 10:12:24 EST 2025 Tue Nov 04 17:54:43 EST 2025 Wed Nov 26 11:31:56 EST 2025 Thu Jan 02 22:54:33 EST 2025 Sat Nov 29 03:17:14 EST 2025 Sat Sep 06 07:31:27 EDT 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 1 |
| Keywords | High sensitivity C-reactive protein Body mass index And multiple imputations Postmenopausal breast cancer Aromatase inhibitors |
| Language | English |
| License | 2023. The Author(s). Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c593t-93b1283b1ef12e2369802f699de317700fb2d5bf2c1e044cb15649fd7f3c4a083 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 ObjectType-Article-2 ObjectType-Undefined-1 ObjectType-Feature-3 content type line 23 |
| ORCID | 0000-0003-0552-5378 |
| OpenAccessLink | https://link.springer.com/10.1186/s13104-023-06301-6 |
| PMID | 36915158 |
| PQID | 2788477804 |
| PQPubID | 55247 |
| PageCount | 5 |
| ParticipantIDs | doaj_primary_oai_doaj_org_article_d99d5ce2c8d442f2ab2f1fd8631f5fe3 pubmedcentral_primary_oai_pubmedcentral_nih_gov_10012500 proquest_miscellaneous_2786813855 proquest_journals_2788477804 gale_infotracmisc_A741172322 gale_infotracacademiconefile_A741172322 gale_incontextgauss_IOV_A741172322 pubmed_primary_36915158 crossref_primary_10_1186_s13104_023_06301_6 springer_journals_10_1186_s13104_023_06301_6 |
| PublicationCentury | 2000 |
| PublicationDate | 2023-03-13 |
| PublicationDateYYYYMMDD | 2023-03-13 |
| PublicationDate_xml | – month: 03 year: 2023 text: 2023-03-13 day: 13 |
| PublicationDecade | 2020 |
| PublicationPlace | London |
| PublicationPlace_xml | – name: London – name: England |
| PublicationTitle | BMC research notes |
| PublicationTitleAbbrev | BMC Res Notes |
| PublicationTitleAlternate | BMC Res Notes |
| PublicationYear | 2023 |
| Publisher | BioMed Central BioMed Central Ltd Springer Nature B.V BMC |
| Publisher_xml | – name: BioMed Central – name: BioMed Central Ltd – name: Springer Nature B.V – name: BMC |
| References | CD Runowicz (6301_CR5) 2016; 34 K Haney (6301_CR11) 2017; 5 6301_CR31 M Protani (6301_CR12) 2010; 123 XA Harrison (6301_CR20) 2018; 6 6301_CR2 Z Babaei (6301_CR29) 2015; 27 SE Bulun (6301_CR33) 2012; 23 FH Shabaruddin (6301_CR25) 2015; 8 P Marques-Vidal (6301_CR37) 2012; 5 6301_CR8 JF Meneses-Echavez (6301_CR9) 2016; 25 K Kleinke (6301_CR21) 2017; 42 T Walsh (6301_CR10) 2010; 107 L Gallicchio (6301_CR41) 2016; 16 U Nur (6301_CR17) 2010; 39 K Baatjes (6301_CR24) 2020; 26 6301_CR19 H-Y Kim (6301_CR39) 2014; 39 6301_CR18 6301_CR38 DL Hertz (6301_CR34) 2017; 18 A MacCiò (6301_CR13) 2011; 11 E Amir (6301_CR15) 2011; 103 R Shah (6301_CR4) 2014; 5 NM Iyengar (6301_CR40) 2019; 5 NJ Park (6301_CR6) 2017; 12 A Macciò (6301_CR1) 2011; 11 CA Thomson (6301_CR7) 2009; 18 CD Nguyen (6301_CR22) 2017; 14 K Lee Chuy (6301_CR3) 2019; 20 DBY Fontein (6301_CR35) 2017; 18 T Hong (6301_CR23) 2013; 31 R Agarwala (6301_CR26) 2018; 46 DSM Chan (6301_CR32) 2020; 17 MC Janelsins (6301_CR30) 2011; 11 6301_CR28 RC Mills (6301_CR36) 2017; 11 6301_CR27 IEG van Hellemond (6301_CR14) 2018; 19 S Boughorbel (6301_CR16) 2016; 11 |
| References_xml | – volume: 11 start-page: 2020 year: 2011 ident: 6301_CR13 publication-title: ScientificWorldJournal doi: 10.1100/2011/806787 – ident: 6301_CR19 doi: 10.1007/s11749-018-0612-4 – volume: 46 start-page: D8 issue: Database issue year: 2018 ident: 6301_CR26 publication-title: Nucleic Acids Res – volume: 27 start-page: 223 issue: 4 year: 2015 ident: 6301_CR29 publication-title: J Egypt Natl Canc Inst doi: 10.1016/j.jnci.2015.09.001 – volume: 26 start-page: 6007 issue: 46 year: 2020 ident: 6301_CR24 publication-title: Curr Pharm Des doi: 10.2174/1381612826666200908141858 – volume: 34 start-page: 611 issue: 6 year: 2016 ident: 6301_CR5 publication-title: J Clin Oncol doi: 10.1200/JCO.2015.64.3809 – ident: 6301_CR8 doi: 10.1155/2013/291546 – volume: 11 start-page: 117822341774397 year: 2017 ident: 6301_CR36 publication-title: Breast Cancer: Basic and Clinical Research doi: 10.1177/1178223417743976 – volume: 17 start-page: 5445 issue: 15 year: 2020 ident: 6301_CR32 publication-title: Cancer Epidemiol Biomarkers Prev – volume: 103 start-page: 1299 issue: 17 year: 2011 ident: 6301_CR15 publication-title: J Natl Cancer Inst doi: 10.1093/jnci/djr242 – volume: 39 start-page: 74 issue: 1 year: 2014 ident: 6301_CR39 publication-title: Restor Dent Endod doi: 10.5395/rde.2014.39.1.74 – volume: 123 start-page: 627 issue: 3 year: 2010 ident: 6301_CR12 publication-title: Breast Cancer Res Treat doi: 10.1007/s10549-010-0990-0 – volume: 5 start-page: 283 issue: 3 year: 2014 ident: 6301_CR4 publication-title: World J Clin Oncol doi: 10.5306/wjco.v5.i3.283 – volume: 11 start-page: e0146413 issue: 1 year: 2016 ident: 6301_CR16 publication-title: PLoS ONE doi: 10.1371/journal.pone.0146413 – volume: 39 start-page: 118 issue: 1 year: 2010 ident: 6301_CR17 publication-title: Int J Epidemiol doi: 10.1093/ije/dyp309 – volume: 18 start-page: 481 issue: 5 year: 2017 ident: 6301_CR34 publication-title: Pharmacogenomics doi: 10.2217/pgs-2016-0205 – volume: 20 start-page: 51 year: 2019 ident: 6301_CR3 publication-title: Curr Treat Options Oncol doi: 10.1007/s11864-019-0646-1 – volume: 18 start-page: 2041 issue: 12 year: 2009 ident: 6301_CR7 publication-title: J Womens Health (Larchmt) doi: 10.1089/jwh.2009.1365 – volume: 12 start-page: e0184174 issue: 9 year: 2017 ident: 6301_CR6 publication-title: PLoS ONE doi: 10.1371/journal.pone.0184174 – ident: 6301_CR2 doi: 10.1007/s10549-011-1843-1 – volume: 6 start-page: e4794 year: 2018 ident: 6301_CR20 publication-title: PeerJ doi: 10.7717/peerj.4794 – volume: 42 start-page: 371 issue: 4 year: 2017 ident: 6301_CR21 publication-title: J Educational Behav Stat doi: 10.3102/1076998616687084 – ident: 6301_CR18 – volume: 11 start-page: 161 issue: 3 year: 2011 ident: 6301_CR30 publication-title: Clin Breast Cancer doi: 10.1016/j.clbc.2011.03.013 – volume: 31 start-page: 279 issue: 4 year: 2013 ident: 6301_CR23 publication-title: Cancer Invest doi: 10.3109/07357907.2013.789898 – volume: 14 start-page: 8 year: 2017 ident: 6301_CR22 publication-title: Emerg Themes Epidemiol doi: 10.1186/s12982-017-0062-6 – volume: 19 start-page: 26 issue: 5 year: 2018 ident: 6301_CR14 publication-title: Curr Treat Options Oncol doi: 10.1007/s11864-018-0541-1 – volume: 23 start-page: 83 issue: 2 year: 2012 ident: 6301_CR33 publication-title: Trends Endocrinol Metab doi: 10.1016/j.tem.2011.10.003 – volume: 16 start-page: e23 issue: 3 year: 2016 ident: 6301_CR41 publication-title: Clin Breast Cancer doi: 10.1016/j.clbc.2016.02.011 – volume: 107 start-page: 12629 issue: 28 year: 2010 ident: 6301_CR10 publication-title: Proc Natl Acad Sci U S A doi: 10.1073/pnas.1007983107 – ident: 6301_CR31 doi: 10.1155/2013/697521 – volume: 5 start-page: 155 issue: 2 year: 2019 ident: 6301_CR40 publication-title: JAMA Oncol doi: 10.1001/jamaoncol.2018.5327 – volume: 8 start-page: 115 year: 2015 ident: 6301_CR25 publication-title: Pharmacogenomics and Personalized Medicine doi: 10.2147/PGPM.S35063 – ident: 6301_CR28 doi: 10.2217/pme.13.43 – volume: 5 start-page: 2800514 year: 2017 ident: 6301_CR11 publication-title: IEEE J Translational Eng Health Med doi: 10.1109/JTEHM.2017.2761764 – ident: 6301_CR27 doi: 10.1155/2015/145647 – volume: 18 start-page: 481 issue: 5 year: 2017 ident: 6301_CR35 publication-title: Breast Cancer Res Treat – ident: 6301_CR38 doi: 10.1186/1471-2288-11-129 – volume: 11 start-page: 2020 year: 2011 ident: 6301_CR1 publication-title: Sci World J doi: 10.1100/2011/806787 – volume: 25 start-page: 1009 issue: 7 year: 2016 ident: 6301_CR9 publication-title: Cancer Epidemiol Biomarkers Prev doi: 10.1158/1055-9965.EPI-15-1061 – volume: 5 start-page: 734 issue: 5 year: 2012 ident: 6301_CR37 publication-title: Obes Facts doi: 10.1159/000345045 |
| SSID | ssj0061881 |
| Score | 2.3150604 |
| Snippet | Purpose
this study was conducted to assess the impact of AIs on body mass index and high sensitivity as prognostic predictors to be incorporated into point of... this study was conducted to assess the impact of AIs on body mass index and high sensitivity as prognostic predictors to be incorporated into point of care... Purpose this study was conducted to assess the impact of AIs on body mass index and high sensitivity as prognostic predictors to be incorporated into point of... Purposethis study was conducted to assess the impact of AIs on body mass index and high sensitivity as prognostic predictors to be incorporated into point of... Abstract Purpose this study was conducted to assess the impact of AIs on body mass index and high sensitivity as prognostic predictors to be incorporated into... |
| SourceID | doaj pubmedcentral proquest gale pubmed crossref springer |
| SourceType | Open Website Open Access Repository Aggregation Database Index Database Publisher |
| StartPage | 37 |
| SubjectTerms | And multiple imputations Aromatase Aromatase Inhibitors Biomedical and Life Sciences Biomedicine Body fat Body Mass Index Breast cancer Breast Neoplasms - drug therapy Breast Neoplasms - genetics C-Reactive Protein Calcium Cancer Survivors Cancer therapies Care and treatment Clinical outcomes Cohort analysis Cohort Studies Complications and side effects Female Ferritin Genomics Health aspects High sensitivity C-reactive protein Homocysteine Humans Hypertension Inflammation Life Sciences Long-term effects Medicine/Public Health Missing data Obesity Observational studies Patient outcomes Patients Post-menopause Postmenopausal breast cancer Postmenopausal women Postmenopause Research Note Survival Womens health |
| SummonAdditionalLinks | – databaseName: DOAJ Directory of Open Access Journals dbid: DOA link: http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwELZQBRIXxJtAQQYhcQCriZ2Hza0gKpCqwgFQb1bs2G0OxFWSrdRfwV9mxkmWpghx4bKH9VibzIxnvslOviHkZcVTZaHuYK6GWhW5c5gRuWcQCG1qjRTex6klh9XRkTw-Vl8ujfrCnrCJHnhS3F6jVFNYx61s8px7XhvuM9_IUmS-8C7yfALqWYqpKQaXmZTZ8oqMLPeGDFBMziA_MeSYyli5SkORrf_PmHwpKV1tmLzyr2lMRge3ya0ZRdL96ervkGuuu0tuTHMlL-6Rn4ehO2EYdOncr0GDp3UfAJ5C1qJtd9qaFufs0NBRE5oL-gNANI3UiTTOH6JnYcAGdKipNwP8lMHm9ZFadJKeDhuIMOe4v-3oNGroLQ1m-4QXNuDk3X6kkb72Pvl28OHr-49snrzAbKHEyJQwkLfgw_mMOy5KJVPuSzCFA7xRpak3vCmM5zZzaZ5bg5QzyjeVFzavAdU9IDtd6NwjQsFIhSkAWala5YA1jfCFUyKXrobdMk_I68UQ-mwi2NCxMJGlnsymwWw6mk2XCXmHttpKIjl2_AJcRs8uo__lMgl5gZbWSH_RYX_NCWhy0J8-f9f7ALAA0kGUS8irWcgHsLmt59cV4K6QMWslubuShPNp18uLQ-k5PgyaVxJOA5I_JeT5dhl3Ys9b58ImypQyE7IoEvJw8r_tfYNFEInKhMiVZ64Us17p2tPIHo6kW4B704S8WZz493X9XfOP_4fmn5CbPB5CwTKxS3bGfuOekuv2fGyH_lk8wr8AIZRLoA priority: 102 providerName: Directory of Open Access Journals – databaseName: Biological Science Database dbid: M7P link: http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Lb9QwELaggMSF9yNQkEFIHMBqYjtZhwsqiAqkqvQAqDcrduxtDsQl2a3UX8FfZsZJtqQILlz2ENta2zOe-caZfEPIiwVPSwtxB3MVxKrIncOMkJ6BIbSpNUp4H6uW7C8ODtTRUXk4Xrj1Y1rlZBOjoa6DxTvyHQ6xmlwgXc7bkx8Mq0bh29WxhMZlcgVZEkRM3TucLHGRKZVNH8qoYqfPAMtIBl6KIdNUxoqZM4qc_X9a5t9c08W0yQvvTqNL2rv5v4u5RW6MYJTuDtpzm1xy7R1ybShPeXaX_NwP7ZKh7aZj2gcNnlZdAJQLzo827XFjGizXQ0NLTajP6HfA4jQyMNJYxoiehB7z2CE0X_fwVwZz4FfUoq51tF-DoTrF8U1Lh4pFb2gwm4tiGIAFfLsVjSy498jXvQ9f3n9kYwEHZvNSrFgpDLg_-HE-446LolQp90VZ1g5gyyJNveF1bjy3mUultAaZa0pfL7ywsgJweJ9staF1Dwn1uc9NDgCtrErYOWmEz10ppHIVjFYyIa8mSeqTgadDx_hGFXqQuwa56yh3XSTkHQp70xM5tuOD0C31eGR1DfPMreNW1VJyzyvDfeZrVYgMZuNEQp6jqmhk0WgxTWcJO9nrT5-_6V3AaYAMwVgm5OXYyQdQGluNXz3AqpB4a9Zze9YTjrmdN0-qpEcz0-tzPUrIs00zjsTUudaFdexTqEyoPE_Ig0GBN-sGiSCgVQlRM9Webcy8pW2OIwk5cncBfE4T8no6Befz-vvOP_r3Mh6T6zyeT8EysU22Vt3aPSFX7emq6bun8XT_Au9DWJY priority: 102 providerName: ProQuest |
| Title | Long-term effects of aromatase inhibitors on body mass index among postmenopausal breast cancer survivors in Africa: observational cohort study |
| URI | https://link.springer.com/article/10.1186/s13104-023-06301-6 https://www.ncbi.nlm.nih.gov/pubmed/36915158 https://www.proquest.com/docview/2788477804 https://www.proquest.com/docview/2786813855 https://pubmed.ncbi.nlm.nih.gov/PMC10012500 https://doaj.org/article/d99d5ce2c8d442f2ab2f1fd8631f5fe3 |
| Volume | 16 |
| WOSCitedRecordID | wos000948971800002&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVADU databaseName: BioMed Central Open Access Free customDbUrl: eissn: 1756-0500 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0061881 issn: 1756-0500 databaseCode: RBZ dateStart: 20080101 isFulltext: true titleUrlDefault: https://www.biomedcentral.com/search/ providerName: BioMedCentral – providerCode: PRVAON databaseName: DOAJ (Directory of Open Access Journals) customDbUrl: eissn: 1756-0500 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0061881 issn: 1756-0500 databaseCode: DOA dateStart: 20080101 isFulltext: true titleUrlDefault: https://www.doaj.org/ providerName: Directory of Open Access Journals – providerCode: PRVHPJ databaseName: ROAD: Directory of Open Access Scholarly Resources customDbUrl: eissn: 1756-0500 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0061881 issn: 1756-0500 databaseCode: M~E dateStart: 20080101 isFulltext: true titleUrlDefault: https://road.issn.org providerName: ISSN International Centre – providerCode: PRVPQU databaseName: Biological Science Database customDbUrl: eissn: 1756-0500 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0061881 issn: 1756-0500 databaseCode: M7P dateStart: 20090101 isFulltext: true titleUrlDefault: http://search.proquest.com/biologicalscijournals providerName: ProQuest – providerCode: PRVPQU databaseName: Health & Medical Collection customDbUrl: eissn: 1756-0500 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0061881 issn: 1756-0500 databaseCode: 7X7 dateStart: 20090101 isFulltext: true titleUrlDefault: https://search.proquest.com/healthcomplete providerName: ProQuest – providerCode: PRVPQU databaseName: ProQuest Central customDbUrl: eissn: 1756-0500 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0061881 issn: 1756-0500 databaseCode: BENPR dateStart: 20090101 isFulltext: true titleUrlDefault: https://www.proquest.com/central providerName: ProQuest – providerCode: PRVPQU databaseName: Publicly Available Content Database customDbUrl: eissn: 1756-0500 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0061881 issn: 1756-0500 databaseCode: PIMPY dateStart: 20090101 isFulltext: true titleUrlDefault: http://search.proquest.com/publiccontent providerName: ProQuest – providerCode: PRVAVX databaseName: SpringerLINK Contemporary 1997-Present customDbUrl: eissn: 1756-0500 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0061881 issn: 1756-0500 databaseCode: RSV dateStart: 20081201 isFulltext: true titleUrlDefault: https://link.springer.com/search?facet-content-type=%22Journal%22 providerName: Springer Nature |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwELZoCxKX8qaBsjIIiQNETew8HG4takWlsqwKVMvJih17mwNJlexW6q_gLzPjJAspcIBLDvFYicfjmc_J-BtCXqYsyDTsO3yTw14VuXN8xSPrgyPUgVaCW-uqlpyk06mYz7NZfyisHbLdh1-SzlO7ZS2SvTYEJBL5EGN85IkK_WSDbEG4E7gcTz-dDf43CYUIh-Mxf-w3CkGOqf93f_xLQLqeLHntj6kLREd3_m8Id8l2Dzzpfmcp98gNU90nt7pSlFcPyPeTulr46Kdpn-JBa0vzpgZEC4GOltV5qUoszUPriqq6uKLfAHdTx7ZIXckielG3mLMO2_BVC49SmO--pBrtqqHtCpzSJfYvK9pVJ3pLa7X-KAwdsFhvs6SO8fYh-XJ0-Pnde78v1uDrOONLP-MKQh1cjA2ZYTzJRMBskmWFAYiSBoFVrIiVZTo0QRRphSw1mS1Sy3WUAxB8RDarujI7hNrYxioGMJblWQTwVHEbm4xHwuTQW0QeeT3Mn7zoODmk28uIRHYqlqBi6VQsE48c4BSvJZFP292om4Xsl6cs4D1jbZgWRRQxy3LFbGgLkfAQ3sZwj7xAA5HImFFhSs4CNNnK449nch8wGaBAcIweedUL2RpMRef9CQcYFZJsjSR3R5KwpPW4ebBD2buUVrJUwAJCviiPPF83Y09Mk6tMvXIyiQi5iGOPPO7Mdj1umBEEr8IjYmTQI8WMW6ry3BGOI08XQOXAI28Gu_75Xn_X_JN_E39KbjO3NLgf8l2yuWxW5hm5qS-XZdtMyEY6T91VTMjWweF0djpxH1AmmK47g3uz4w-zrxPnC34AsgBVXQ |
| linkProvider | Springer Nature |
| linkToHtml | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1Lb9QwELZKAcGF9yNQwCAQB4ia2EnWQUKoPKquuiw9tKg3Ezt2uwfiZbNb1F_BP-E3MuMkW1IEtx647GFt7_ox881MMv6GkKcDFuUa4o7QFBCrIndOqHhiQwBCHWkluLW-asloMB6L_f18Z4X87O7CYFplh4keqEun8Rn5OoNYLRkgXc6b6bcQq0bh29WuhEYjFtvm-DuEbPXr4Xs432eMbX7YfbcVtlUFQp3mfB7mXAEmw4exMTOMZ7mImM3yvDRgSwdRZBUrU2WZjk2UJFohnUpuy4HlOinAY4HfPUfOgxvBhE8V3OmQP4uFiLuLOSJbr2PwnZIQrGKIzFZxmPWMn68R8Kcl-M0Unk7TPPWu1pvAzav_2-ZdI1daZ5tuNNpxnayY6ga52JTfPL5JfoxcdRCibaJtWgt1lhYzB148GHc6qQ4naoLliKirqHLlMf0KsQb1DJPUl2miU1djnr6bFosa_kphjv-catSlGa0XAMRHOH5S0aYi0yvq1PJBOAzAAsWzOfUsv7fI3pnsxm2yWrnK3CXUpjZVKTigeZHDSSWK29TkPBGmgNEiCciLTnLktOEhkT5-E5ls5EyCnEkvZzILyFsUrmVP5BD3X7jZgWwhSZYwz1QbpkWZJMyyQjEb21JkPIbZGB6QJyiaEllCKkxDOoCdrOXw02e5AX4oeL5gDALyvO1kHQipLtpbHbAqJBbr9Vzr9QQY0_3mTnRlC6O1PJHbgDxeNuNITA2sjFv4PpmIuUjTgNxpFGa5bjgRdNhFQERPlXob02-pJoeeZB25ySA8iALystO6k3n9fefv_XsZj8ilrd2PIzkajrfvk8vMYwMPY75GVuezhXlALuij-aSePfTIQsmXs9bGX6YOtBM |
| linkToPdf | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Lb9QwELagPMSF9yNQwCAkDhA1sZOsza08VlSsSiWg6s2KHXubA8kqyVbqr-AvM-MkS1PggLjsYT3WxuN5fN6MvyHkxYxF0sC5I7Q5nFWROyfUPHEhBEITGS24c75ryWK2vy-OjuTBmVv8vtp9fCXZ32lAlqaq21kVrndxke20MaCSJIR8EyJnVBxmF8mlBJsG4Xn9y-EYi7NYiHi8KvPHeZN05Fn7f4_NZ5LT-cLJc29PfVKa3_j_5dwk1wdASnd7C7pFLtjqNrnSt6g8vUN-LOpqGWL8pkPpB60dzZsakC4kQFpWx6UusWUPrSuq6-KUfgc8Tj0LI_WtjOiqbrGWHY7n6xZ-SmMdfEcN2ltD2zUEqxOcX1a071r0htZ682cxTMAmvk1HPRPuXfJt_uHru4_h0MQhNKnkXSi5hhQIH9bFzDKeSRExl0lZWIAusyhymhWpdszENkoSo5G9Rrpi5rhJcgCI98hWVVf2AaEudalOAaTJXCYAWzV3qZU8ETaH2SIJyKtxL9Wq5-pQ_owjMtWrWIGKlVexygLyFrd7I4k82_6LulmqwW1VAc-ZGsuMKJKEOZZr5mJXiIzH8DSWB-Q5GotCJo0KS3WWoMlW7X0-VLuA1QAdQsAMyMtByNVgNiYfbj7AqpB8ayK5PZEEVzfT4dEm1RBqWsVmAhwLeaQC8mwzjDOxfK6y9drLZCLmIk0Dcr834c26YUcQ1IqAiIlxTxQzHanKY09EjvxdAKGjgLwebfzXc_1d8w__TfwpuXrwfq4We_ufHpFrzHsJD2O-Tba6Zm0fk8vmpCvb5ol3_Z9qnFog |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Long-term+effects+of+aromatase+inhibitors+on+body+mass+index+among+postmenopausal+breast+cancer+survivors+in+Africa%3A+observational+cohort+study&rft.jtitle=BMC+research+notes&rft.au=Milambo%2C+Jean+Paul+Muambangu&rft.au=Nyasulu%2C+Peter+S&rft.au=Akudugu%2C+John+M&rft.au=Ndirangu%2C+James&rft.date=2023-03-13&rft.eissn=1756-0500&rft.volume=16&rft.issue=1&rft.spage=37&rft_id=info:doi/10.1186%2Fs13104-023-06301-6&rft_id=info%3Apmid%2F36915158&rft.externalDocID=36915158 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1756-0500&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1756-0500&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1756-0500&client=summon |